Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?

Arteriovenous fistula (AVF) thrombosis is a major vascular access complication in hemodialysis (HD) patients, contributing to increased morbidity. Statins, known for their pleiotropic effects, may reduce AVF thrombosis risk, but evidence on dose-dependent effects is limited. This study evaluated th...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalia Stepanova, Tetyana Ostapenko, Valeriia Marchenko, Alina Holovanova, Mariia Lysii, Tetyana Kucher, Viacheslav Filonov, Victor Dzhur, Bohdan Stetsenko, Hanna Moroid, Nataliia Pavchak, Kateryna Rusyn, Oksana Rusyn, Bohdan Radiuk
Format: Article
Language:English
Published: National Kidney Foundation of Ukraine 2025-04-01
Series:Український Журнал Нефрології та Діалізу
Subjects:
Online Access:https://ukrjnd.com.ua/index.php/journal/article/view/952
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850101911192076288
author Natalia Stepanova
Tetyana Ostapenko
Valeriia Marchenko
Alina Holovanova
Mariia Lysii
Tetyana Kucher
Viacheslav Filonov
Victor Dzhur
Bohdan Stetsenko
Hanna Moroid
Nataliia Pavchak
Kateryna Rusyn
Oksana Rusyn
Bohdan Radiuk
author_facet Natalia Stepanova
Tetyana Ostapenko
Valeriia Marchenko
Alina Holovanova
Mariia Lysii
Tetyana Kucher
Viacheslav Filonov
Victor Dzhur
Bohdan Stetsenko
Hanna Moroid
Nataliia Pavchak
Kateryna Rusyn
Oksana Rusyn
Bohdan Radiuk
author_sort Natalia Stepanova
collection DOAJ
description Arteriovenous fistula (AVF) thrombosis is a major vascular access complication in hemodialysis (HD) patients, contributing to increased morbidity. Statins, known for their pleiotropic effects, may reduce AVF thrombosis risk, but evidence on dose-dependent effects is limited. This study evaluated the association between statin use, dose intensity, and AVF thrombosis in HD patients. Methods. A multicenter, retrospective cohort study was conducted using data from 562 HD patients with native AVFs across 10 dialysis clinics (May 2021–April 2025). Patients were categorized by statin use (users vs. non-users) and dose intensity (moderate vs. high vs. none). The primary outcome was AVF thrombosis; death was treated as a competing event. Kaplan-Meier survival curves and Fine and Gray subdistribution hazard models, adjusted for age, diabetes, dialysis vintage, Kt/V, glucose, calcium, blood flow, and pre-HD cardiovascular disease, were used to assess thrombosis risk. Results. Of 562 patients (median follow-up 59 months), 212 (37.7%) were statin users. AVF thrombosis occurred in 54 (9.6%) patients, with 11 (7.1%) in statin users vs. 43 (10.6%) in non-users (p = 0.006). Kaplan-Meier analysis showed lower thrombosis probability in statin users (log-rank p = 0.001), with high-intensity users having the lowest risk (p = 0.004). In the unadjusted Fine and Gray model, high-intensity statins were associated with reduced thrombosis risk (sHR 0.61, 95% CI 0.59–0.97, p = 0.03), with a significant dose-dependent trend (p = 0.018). The adjusted model showed no significant association (moderate: sHR 0.67, p = 0.16; high: sHR 0.57, p = 0.26). Conclusions. Statin use, particularly high-intensity, may reduce AVF thrombosis risk in HD patients, with a dose-dependent trend in unadjusted analyses. However, adjusted results were non-significant, possibly due to limited events. Larger prospective studies are needed to confirm these findings and optimize statin therapy for vascular access preservation.
format Article
id doaj-art-ecb78741a231420f84ee6cfb141bf460
institution DOAJ
issn 2304-0238
2616-7352
language English
publishDate 2025-04-01
publisher National Kidney Foundation of Ukraine
record_format Article
series Український Журнал Нефрології та Діалізу
spelling doaj-art-ecb78741a231420f84ee6cfb141bf4602025-08-20T02:39:54ZengNational Kidney Foundation of UkraineУкраїнський Журнал Нефрології та Діалізу2304-02382616-73522025-04-012(86)10.31450/ukrjnd.2(86).2025.03Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?Natalia Stepanova0Tetyana Ostapenko1Valeriia Marchenko2Alina Holovanova3Mariia Lysii4Tetyana Kucher5Viacheslav Filonov6Victor Dzhur7Bohdan Stetsenko8Hanna Moroid9Nataliia Pavchak10Kateryna Rusyn11Oksana Rusyn12Bohdan Radiuk13State Institution “O.O. Shalimov National Scientific Center of Surgery and Transplantology of the National Academy of Medical Science of Ukraine,” Kyiv, Ukraine; Medical Center “Nephrocenter,” Kyiv, Ukraine Medical Center “Nephrocenter,” Zaporizhzhia, UkraineMedical Center “Nephrocenter,” Zaporizhzhia, UkraineMedical Center “Nephrocenter,” Zaporizhzhia, UkraineMedical Center “Nephrocenter,” Stryi, UkraineMedical Center “Nephrocenter,” Sarny, UkraineMedical Center “Nephrocenter,” Odesa, UkraineMedical Center “Nephrocenter,” Kyiv, UkraineMedical Center “Nephrocenter,” Kyiv, UkraineMedical Center “Nephrocenter,” Sheptytskyi, UkraineMedical Center “Nephrocenter,” Drohobych, UkraineMedical Center “Nephrocenter,” Lviv, UkraineMedical Center “Nephrocenter,” Lviv, UkraineMedical Center “Nephrocenter,” Gorodok, Ukraine Arteriovenous fistula (AVF) thrombosis is a major vascular access complication in hemodialysis (HD) patients, contributing to increased morbidity. Statins, known for their pleiotropic effects, may reduce AVF thrombosis risk, but evidence on dose-dependent effects is limited. This study evaluated the association between statin use, dose intensity, and AVF thrombosis in HD patients. Methods. A multicenter, retrospective cohort study was conducted using data from 562 HD patients with native AVFs across 10 dialysis clinics (May 2021–April 2025). Patients were categorized by statin use (users vs. non-users) and dose intensity (moderate vs. high vs. none). The primary outcome was AVF thrombosis; death was treated as a competing event. Kaplan-Meier survival curves and Fine and Gray subdistribution hazard models, adjusted for age, diabetes, dialysis vintage, Kt/V, glucose, calcium, blood flow, and pre-HD cardiovascular disease, were used to assess thrombosis risk. Results. Of 562 patients (median follow-up 59 months), 212 (37.7%) were statin users. AVF thrombosis occurred in 54 (9.6%) patients, with 11 (7.1%) in statin users vs. 43 (10.6%) in non-users (p = 0.006). Kaplan-Meier analysis showed lower thrombosis probability in statin users (log-rank p = 0.001), with high-intensity users having the lowest risk (p = 0.004). In the unadjusted Fine and Gray model, high-intensity statins were associated with reduced thrombosis risk (sHR 0.61, 95% CI 0.59–0.97, p = 0.03), with a significant dose-dependent trend (p = 0.018). The adjusted model showed no significant association (moderate: sHR 0.67, p = 0.16; high: sHR 0.57, p = 0.26). Conclusions. Statin use, particularly high-intensity, may reduce AVF thrombosis risk in HD patients, with a dose-dependent trend in unadjusted analyses. However, adjusted results were non-significant, possibly due to limited events. Larger prospective studies are needed to confirm these findings and optimize statin therapy for vascular access preservation. https://ukrjnd.com.ua/index.php/journal/article/view/952hemodialysis, arteriovenous fistula, thrombosis, statins, risk, treatment.
spellingShingle Natalia Stepanova
Tetyana Ostapenko
Valeriia Marchenko
Alina Holovanova
Mariia Lysii
Tetyana Kucher
Viacheslav Filonov
Victor Dzhur
Bohdan Stetsenko
Hanna Moroid
Nataliia Pavchak
Kateryna Rusyn
Oksana Rusyn
Bohdan Radiuk
Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
Український Журнал Нефрології та Діалізу
hemodialysis, arteriovenous fistula, thrombosis, statins, risk, treatment.
title Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
title_full Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
title_fullStr Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
title_full_unstemmed Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
title_short Retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis: Is there a dose-dependent effect?
title_sort retrospective analysis of statin use and arteriovenous fistula thrombosis in hemodialysis is there a dose dependent effect
topic hemodialysis, arteriovenous fistula, thrombosis, statins, risk, treatment.
url https://ukrjnd.com.ua/index.php/journal/article/view/952
work_keys_str_mv AT nataliastepanova retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT tetyanaostapenko retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT valeriiamarchenko retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT alinaholovanova retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT mariialysii retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT tetyanakucher retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT viacheslavfilonov retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT victordzhur retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT bohdanstetsenko retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT hannamoroid retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT nataliiapavchak retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT katerynarusyn retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT oksanarusyn retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect
AT bohdanradiuk retrospectiveanalysisofstatinuseandarteriovenousfistulathrombosisinhemodialysisisthereadosedependenteffect